Net Income (TTM) Chart

View Net Income (TTM) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -286.04M
March 31, 2026 -272.70M
December 31, 2025 -276.48M
September 30, 2025 -297.59M
June 30, 2025 -311.55M
March 31, 2025 -333.39M
December 31, 2024 -337.71M
September 30, 2024 -345.20M
June 30, 2024 -322.83M
March 31, 2024 -329.12M
December 31, 2023 -341.97M
September 30, 2023 -325.98M
June 30, 2023 -344.42M
March 31, 2023 -322.70M
Date Value
December 31, 2022 -290.51M
September 30, 2022 -290.46M
June 30, 2022 -267.12M
March 31, 2022 -383.73M
December 31, 2021 -363.87M
September 30, 2021 -261.14M
June 30, 2021 -236.38M
March 31, 2021 -69.71M
December 31, 2020 -52.41M
September 30, 2020 -111.60M
June 30, 2020 -95.20M
March 31, 2020 -86.01M
December 31, 2019 -75.30M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
AbbVie, Inc. 6.274B
TG Therapeutics, Inc. 441.49M
Karyopharm Therapeutics, Inc. -224.74M
Krystal Biotech, Inc. 241.46M
Akebia Therapeutics, Inc. -29.67M